Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of pioglitazone, twice daily (BID),
combined with metformin versus pioglitazone taken alone and metformin taken alone in treating
Type 2 Diabetes Mellitus.